Kurm Pharma ApS: Financial statements 2021
CVR: 39181274
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Kurm Pharma ApS (CVR 39181274) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 2,610,379 and a net result of DKK 1,996,154 compared with DKK 704,980 the year before. That is an increase of 175.6% compared with the year before. Equity in the 2021 report amounted to DKK 3,105,235. The solvency ratio was 64%.
- Gross Profit
- DKK 2,610,379
- Profit/Loss
- DKK 1,996,154
- Equity
- DKK 3,105,235
- Total Assets
- DKK 4,849,816
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 2.6 mio. | 2 mio. | 3.1 mio. | - |
| 2020 | - | 947 t. | 705 t. | 969 t. | - |
| 2019 | - | 667 t. | 506 t. | 904 t. | - |
| 2018 | - | 494 t. | 348 t. | 398 t. | - |
Official annual report
Find more companies like Kurm Pharma ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Kurm Pharma ApS has published its annual report for 2020. Gross profit came to DKK 947,022, and the net result was DKK 704,980.
About Kurm Pharma ApS
Kurm Pharma ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2017. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The management consists of Jacob Gjelstrup and Jesper Gjelstrup. The board consists of Steen Nordstrøm (chair), Allan Christensen, Jacob Gjelstrup and Jesper Gjelstrup. The company is owned by Fitzrovia ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -2,598,150 and a net result of DKK -1,978,646 compared with DKK 602,189 the year before. Equity in the 2025 report amounted to DKK 1,813,033.